3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
22
Immunoglobulin Light-chain Amyloidosis
4
Waldenstrom Macroglobulinemia
3
Recurrence
2
Lymphoma, T-Cell, Peripheral
2
Smoldering Multiple Myeloma
1
Sarcoma, Kaposi
1
Proteostasis Deficiencies
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm, Residual
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematologic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Amyloidosis
1
Interventions
atezolizumab
3
Specimen Handling
2
spartalizumab
1
selinexor
1
sargramostim
1
pembrolizumab
1
pazopanib
1
fludarabine
1
cediranib
1
cabozantinib
1
atropine sulfate-diphenoxylate hydrochloride drug combination
1
anlotinib
1
Zoledronic Acid
1
Warfarin
1
Vitamin B 6
1
Thyroxine
1
Tablets
1
Sunitinib
1
Rosuvastatin Calcium
1
Radiotherapy
1
Radiation
1
Pyridoxine
1
Promethazine
1
Prochlorperazine
1
Petrolatum
1
Midazolam
1
Lorazepam
1
Loperamide
1
Immunoglobulin G
1
Ifosfamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Alveolar Soft Part
×
ixazomib
×
1 year
×
Clear all
No trials found.